(Q34150097)

31 July 2017

title

Ovarian cancer biomarkers for molecular biosensors and translational medicine (English)

1 reference

31 July 2017

0 references

1 reference

K Stephen Suh

1

1 reference

31 July 2017

Sang W Park

2

1 reference

31 July 2017

Angelica Castro

3

1 reference

31 July 2017

Hiren Patel

4

1 reference

31 July 2017

Patrick Blake

5

1 reference

31 July 2017

Michael Liang

6

1 reference

31 July 2017

Andre Goy

7

1 reference

31 July 2017

publication date

1 November 2010

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

1069-1083

1 reference

31 July 2017

cites work

Cancer statistics, 2008

1 reference

The detection, treatment, and biology of epithelial ovarian cancer

21 January 2018

1 reference

The biology of ovarian cancer: new opportunities for translation

21 January 2018

1 reference

Accuracy of ultrasonography with color Doppler in ovarian tumor: a systematic quantitative review.

21 January 2018

1 reference

Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.

21 January 2018

1 reference

Early diagnosis and predictors of malignancy of adnexal masses

21 January 2018

1 reference

Genetic factors in ovarian carcinoma

21 January 2018

1 reference

Cancer antigen 125 and prognosis

21 January 2018

1 reference

Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125

21 January 2018

1 reference

CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

21 January 2018

1 reference

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

21 January 2018

1 reference

Validation of referral guidelines for women with pelvic masses

21 January 2018

1 reference

Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker

21 January 2018

1 reference

VSGP/F-spondin: a new ovarian cancer marker

21 January 2018

1 reference

F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activation.

21 January 2018

1 reference

The activity of thymidine phosphorylase as a new ovarian tumor marker

21 January 2018

1 reference

The dual role of thymidine phosphorylase in cancer development and chemotherapy

21 January 2018

1 reference

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

21 January 2018

1 reference

Emerging roles of proteases in tumour suppression

21 January 2018

1 reference

Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment

21 January 2018

1 reference

Role of nerve growth factor and FSH receptor in epithelial ovarian cancer

21 January 2018

1 reference

Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha

21 January 2018

1 reference

The physiological role of hormones in saliva

21 January 2018

1 reference

Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer

21 January 2018

1 reference

NF-kappaB activation in endothelial cells is critical for the activity of angiostatic agents

21 January 2018

1 reference

Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism.

21 January 2018

1 reference

Angiostatin inhibits monocyte/macrophage migration via disruption of actin cytoskeleton.

21 January 2018

1 reference

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other

21 January 2018

1 reference

Phase II biomarker trial of a multimarker diagnostic for ovarian cancer

21 January 2018

1 reference

Clinical evaluations of a new ovarian cancer marker, COX‐1

21 January 2018

1 reference

The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms

21 January 2018

1 reference

HE4 as a biomarker for ovarian and endometrial cancer management

21 January 2018

1 reference

Development of a multimarker assay for early detection of ovarian cancer

21 January 2018

1 reference

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study

21 January 2018

1 reference

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

21 January 2018

1 reference

Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin

21 January 2018

1 reference

Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma

21 January 2018

1 reference

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma

21 January 2018

1 reference

Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients

21 January 2018

1 reference

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

21 January 2018

1 reference

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study

21 January 2018

1 reference

Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer

21 January 2018

1 reference

Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.

21 January 2018

1 reference

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

21 January 2018

1 reference

Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma

21 January 2018

1 reference

Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer

21 January 2018

1 reference

Expressions of estrogen and progesterone receptors in epithelial ovarian cancer: a clinicopathologic study

21 January 2018

1 reference

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

21 January 2018

1 reference

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

21 January 2018

1 reference

Reciprocal modifications of CLIC4 in tumor epithelium and stroma mark malignant progression of multiple human cancers

21 January 2018

1 reference

Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma

21 January 2018

1 reference

Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer

21 January 2018

1 reference

Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker

21 January 2018

1 reference

Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma

21 January 2018

1 reference

Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma

21 January 2018

1 reference

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

21 January 2018

1 reference

Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression

21 January 2018

1 reference

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.

21 January 2018

1 reference

M-CAM expression as marker of poor prognosis in epithelial ovarian cancer

21 January 2018

1 reference

Therapeutic Targeting of ATP7B in Ovarian Carcinoma.

21 January 2018

1 reference

Progesterone as a possible tumor marker for "nonendocrine" ovarian malignant tumors.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.10.87

1 reference

31 July 2017

1 reference